Dr. Leigh Ann Martin is a pharmacist who is specialized in Pharmacotherapy in Louisville, Kentucky. Patients can reach her at 800 Zorn Ave, Louisville Vamc , Pharmacy Dept 119, Louisville or contact her on 502-287-5305. Active license number of Dr. Leigh Ann Martin is 010852 for Pharmacotherapy in Kentucky. Dr. Leigh Ann Martin is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Leigh Ann Martin speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Leigh Ann Martin are as mentioned below.
NPI Number:
1598861858
NPI Enumeration Date:
15 Sep, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Leigh Ann Martin are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
010852
Kentucky
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
58 Osage Trl, Louisville, Kentucky
Zip:
40245-7018
Phone Number:
502-290-5653
Fax Number:
--
Patients can reach Dr. Leigh Ann Martin at 800 Zorn Ave, Louisville Vamc , Pharmacy Dept 119, Louisville, Kentucky or can call on phone at 502-287-5305.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.